Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 7/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.36 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23820146 | 0.90 | PRKDC (0.39) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL26047449 | 0.89 | ALOX5 (0.39) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL23822091 | 0.88 | ALOX5 (0.38) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL23821463 | 0.87 | ALOX5 (0.39) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22375865 | 0.86 | PRKDC (0.40) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22376497 | 0.86 | ALOX5 (0.40) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22375906 | 0.86 | PRKDC (0.41) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL22375871 | 0.86 | PRKDC (0.40) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL23822411 | 0.86 | ALOX5 (0.43) | PRKDCPIK3CDPIK3CBALOX5TDP1 | |
| SCHEMBL23820458 | 0.86 | ALOX5 (0.38) | PRKDCPIK3CDPIK3CBBRD4PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4276924-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-11-15 | — | — | EP | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-11-02 | — | — | US | disclosed |
| EP-4243102-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4243100-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4235829-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-08-30 | — | — | EP | disclosed |
| WO-2023132694-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-07-13 | — | — | WO | disclosed |
| EP-3972001-B1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023003436-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-01-26 | — | — | WO | disclosed |
| WO-2022086296-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2022-04-28 | — | — | WO | disclosed |
| WO-2022086297-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2022-04-28 | — | — | WO | disclosed |
| EP-3972001-A1 | ORGANIC LIGHT EMITTING DEVICE | LG Chem, Ltd. (KR) | 2022-03-23 | — | — | EP | disclosed |
| WO-2021230714-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-11-18 | — | — | WO | disclosed |
| WO-2021230715-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2021-11-18 | — | — | WO | disclosed |
| WO-2021182893-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2021-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230354706-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY2, CRY1, PER2 | PRKDC 4266/4885PIK3CD 4249/4885PIK3CB 4699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.